Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Androgens and other hormones affect hair growth and skin conditions like acne.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Antiandrogen therapy may help treat hidradenitis suppurativa.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

Alopecia areata's causes are unclear, treatments exist but relapses are common.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

The emulgel with specific ingredients was effective for treating hair loss.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

The "Flavosterol" emulgel meets quality standards for treating hair loss.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Emulgels are effective for delivering skin medications and cosmetics due to their easy application and controlled release.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.